Deepa S. Subramaniam

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

Giuseppe Giaccone, Chul Kim, Jillian Thompson et al. · The Lancet Oncology · 2018 · 400 citations · Full text

Medicine, Oncology, Pharmacology +10

Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update.

Sushma Jonna, Deepa S. Subramaniam · PubMed · 2019 · 233 citations

Medicine, Molecular Genetics, Oncology +12

Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells

Simon J. Dovedi, Matthew J. Elder, Chunning Yang et al. · Cancer Discovery · 2021 · 180 citations

Life Sciences, Immunology, Oncology +17

Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer

Brian T. Collins, Saloomeh Vahdat, Kelly Erickson et al. · Journal of Hematology & Oncology · 2009 · 131 citations · Full text

Medicine, Radiation Oncology, Clinical Radiation Oncology +11

CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance

Kang-Seo Park, Mark Raffeld, Yong Wha Moon et al. · Journal of Clinical Investigation · 2014 · 126 citations · Full text

Medicine, Oncology, Pharmacology +17